Marker Therapeutics, Inc.
MRKR • NASDAQ
Marker Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Juan F. Vera, with a market cap of $29.2M.
Market Cap$29.2M
Employees8.0
CEOJuan F. Vera
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Marker Therapeutics, Inc. FAQ
Common questions about Marker Therapeutics, Inc.
Marker Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $649.2K.
Marker Therapeutics, Inc. has approximately 8 employees.